The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Depression in PD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Participants in the Experimental group underwent fourteen consecutive daily sessions oftranscutaneous auricular vagus nerve stimulation (taVNS, twice daily, 30 minutes eachtime) , whereas participants in the sham stimulation group underwent fourteen consecutivedaily sessions of sham taVNS. Assessments of depression symptoms, motor symptoms wereperformed three times: at baseline, one day post intervention and 2 weeks postintervention. The cortical activity (using Functional near‐infrared spectroscopy) wereassessed at baseline, one day post intervention.
Epistemonikos ID: 6d42e4b465a1e2bd7d4fbc63a022e7194c39c7b4
First added on: Jul 02, 2026